PROSTATE NEOPLASM
Clinical trials for PROSTATE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATE NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
Prostate cancer study seeks to lower drug doses without losing effect
Disease control TerminatedThis study aimed to find the lowest effective dose of the prostate cancer drug abiraterone for men starting treatment. Researchers planned to enroll 50 men and test different doses over 12 weeks, measuring hormone levels and PSA. The study was terminated early, so results are lim…
Matched conditions: PROSTATE NEOPLASM
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC